Gábor Pozsgai Selected Research

somatostatin receptor subtype-4

1/2018	Role of Transient Receptor Potential Ankyrin 1 Ion Channel and Somatostatin sst4 Receptor in the Antinociceptive and Anti-inflammatory Effects of Sodium Polysulfide and Dimethyl Trisulfide.
8/2009	Impaired defense mechanism against inflammation, hyperalgesia, and airway hyperreactivity in somatostatin 4 receptor gene-deleted mice.
1/2008	Inhibitory effects of synthetic somatostatin receptor subtype 4 agonists on acute and chronic airway inflammation and hyperreactivity in the mouse.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gábor Pozsgai Research Topics

Disease

10	Inflammation (Inflammations) 01/2019 - 05/2007
6	Hyperalgesia 05/2022 - 08/2009
4	Arthritis (Polyarthritis) 05/2022 - 08/2009
4	Pain (Aches) 01/2019 - 08/2009
4	Bronchial Hyperreactivity 08/2009 - 05/2007
3	Edema (Dropsy) 01/2019 - 05/2007
2	Neuralgia (Stump Neuralgia) 03/2021 - 11/2020
2	Neurogenic Inflammation 11/2020 - 06/2007
2	Hypersensitivity (Allergy) 01/2016 - 08/2009
2	Hyperplasia 08/2009 - 05/2007
1	Rheumatoid Arthritis 01/2019
1	Pathologic Processes 01/2019
1	Knee Osteoarthritis 01/2016
1	Colitis 02/2015
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2015
1	Pneumonia (Pneumonitis) 01/2008
1	Respiratory Hypersensitivity 06/2007
1	Dermatitis 12/2005
1	Allergic Contact Dermatitis 12/2005
1	Contact Dermatitis (Eczema, Contact) 12/2005

Drug/Important Bio-Agent (IBA)

6	Peroxidase (Myeloperoxidase)IBA 05/2022 - 05/2007
3	CarrageenanIBA 01/2018 - 08/2009
3	somatostatin receptor subtype-4IBA 01/2018 - 01/2008
3	NeuropeptidesIBA 01/2014 - 12/2005
3	LipopolysaccharidesIBA 08/2009 - 05/2007
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 08/2009 - 05/2007
2	Ion Channels (Ion Channel)IBA 05/2022 - 01/2019
2	dimethyl trisulfideIBA 05/2022 - 03/2021
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2019 - 02/2015
2	AnkyrinsIBA 01/2019 - 01/2016
2	SodiumIBA 01/2018 - 02/2015
2	Calcitonin Gene-Related PeptideIBA 01/2014 - 06/2007
2	Capsaicin (Zostrix)FDA Link 01/2008 - 06/2007
2	EndotoxinsIBA 06/2007 - 05/2007
1	Pharmaceutical PreparationsIBA 11/2020
1	Blood Proteins (Serum Proteins)IBA 11/2020
1	GasotransmittersIBA 01/2019
1	GYY 4137IBA 01/2019
1	Sulfides (Thioethers)IBA 01/2019
1	CalciumIBA 01/2017
1	Analgesics (Analgesic Drugs)IBA 01/2017
1	Ligand-Gated Ion ChannelsIBA 01/2017
1	Iodoacetic AcidIBA 01/2016
1	Freund's AdjuvantIBA 01/2016
1	EnzymesIBA 02/2015
1	Drinking WaterIBA 02/2015
1	SolutionsIBA 02/2015
1	Dextran SulfateIBA 02/2015
1	sodium bisulfide (NaHS)IBA 02/2015
1	TachykininsIBA 01/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2009
1	OxazoloneIBA 08/2009
1	OvalbuminIBA 01/2008
1	TT2-32IBA 01/2008
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2008
1	PeptidomimeticsIBA 01/2008
1	2S)- 4- amino- N- (1'- carbamoyl- 2'- phenylethyl)- 2- (4''- methyl- 1''- naphthalenesulfonylamino)butanamide (1'SIBA 01/2008
1	resiniferatoxinIBA 06/2007
1	NK 2 (NK-2)IBA 06/2007
1	SR 48968 (saredutant)IBA 06/2007
1	Substance PIBA 06/2007
1	SR 140333IBA 06/2007
1	TRPV Cation ChannelsIBA 12/2005
1	TRPV1 receptorIBA 12/2005

Therapy/Procedure

2	Ligation 03/2021 - 11/2020
2	Oral Administration 11/2020 - 02/2015
1	Drug Therapy (Chemotherapy) 03/2021
1	Therapeutics 02/2015
1	Intranasal Administration 05/2007